S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
Log in
CVE:VIV

Avivagen Inc. (VIV.V) Stock Forecast, Price & News

C$0.64
+0.02 (+3.23 %)
(As of 01/15/2021 03:18 PM ET)
Add
Compare
Today's Range
C$0.63
Now: C$0.64
C$0.65
50-Day Range
C$0.51
MA: C$0.59
C$0.66
52-Week Range
C$0.39
Now: C$0.64
C$0.77
Volume59,000 shs
Average Volume42,654 shs
Market CapitalizationC$26.73 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Avivagen Inc. develops and commercializes various products to replace antibiotics in livestock feeds to optimize the health and growth of the animals by supporting the animal's own health defenses. The company offers products based on its OxC-Beta technology, such as OxC-beta Livestock, a premix for livestock feeds; and Vivamune Health Chews supplements for companion animals. It has operations in Mexico and Latin America. The company was formerly known as Chemaphor, Inc. and changed its name to Avivagen Inc.in May 2012. The company was founded in 2005 and is headquartered in Ottawa, Canada.

MarketRank

Overall MarketRank

0.50 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone613-949-8164
Employees13

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$1.18 million
Cash FlowC$0.02 per share
Book ValueC($0.11) per share

Profitability

Miscellaneous

Market CapC$26.73 million
Next Earnings Date3/3/2021 (Estimated)
OptionableOptionable
C$0.64
+0.02 (+3.23 %)
(As of 01/15/2021 03:18 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VIV News and Ratings via Email

Sign-up to receive the latest news and ratings for VIV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Avivagen Inc. (VIV.V) (CVE:VIV) Frequently Asked Questions

How has Avivagen Inc. (VIV.V)'s stock been impacted by Coronavirus?

Avivagen Inc. (VIV.V)'s stock was trading at C$0.60 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, VIV stock has increased by 6.7% and is now trading at C$0.64.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Avivagen Inc. (VIV.V)?

Wall Street analysts have given Avivagen Inc. (VIV.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Avivagen Inc. (VIV.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Avivagen Inc. (VIV.V)'s next earnings date?

Avivagen Inc. (VIV.V) is scheduled to release its next quarterly earnings announcement on Wednesday, March 3rd 2021.
View our earnings forecast for Avivagen Inc. (VIV.V)
.

How were Avivagen Inc. (VIV.V)'s earnings last quarter?

Avivagen Inc. (VIV.V) (CVE:VIV) issued its quarterly earnings results on Tuesday, December, 15th. The company reported ($0.03) earnings per share for the quarter. The firm earned $0.29 million during the quarter.
View Avivagen Inc. (VIV.V)'s earnings history
.

Who are some of Avivagen Inc. (VIV.V)'s key competitors?

What other stocks do shareholders of Avivagen Inc. (VIV.V) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avivagen Inc. (VIV.V) investors own include Antibe Therapeutics Inc. (ATE.V) (ATE), Astrotech (ASTC), Arcturus Therapeutics (ARCT), (AQB), Aptose Biosciences (APTO), Appili Therapeutics (APLIF), Argan (AGX), Applied Genetic Technologies (AGTC), The AES (AES) and AbbVie (ABBV).

Who are Avivagen Inc. (VIV.V)'s key executives?

Avivagen Inc. (VIV.V)'s management team includes the following people:
  • Mr. G. F. Kym Anthony, CEO, Pres & Director (Age 64, Pay $362.31k)
  • Dr. Graham Burton, Co-Founder, Chief Scientific Officer & Director
  • Mr. Christopher Boland, Chief Financial Officer
  • Mr. Drew Basek, Director of Investor Relations
  • Ms. Tracy Gillett BVSC, Marketing Mang.

What is Avivagen Inc. (VIV.V)'s stock symbol?

Avivagen Inc. (VIV.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "VIV."

How do I buy shares of Avivagen Inc. (VIV.V)?

Shares of VIV and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is Avivagen Inc. (VIV.V)'s stock price today?

One share of VIV stock can currently be purchased for approximately C$0.64.

How big of a company is Avivagen Inc. (VIV.V)?

Avivagen Inc. (VIV.V) has a market capitalization of C$26.73 million and generates C$1.18 million in revenue each year. Avivagen Inc. (VIV.V) employs 13 workers across the globe.

What is Avivagen Inc. (VIV.V)'s official website?

The official website for Avivagen Inc. (VIV.V) is www.avivagen.com.

How can I contact Avivagen Inc. (VIV.V)?

The company can be reached via phone at 613-949-8164.

This page was last updated on 1/17/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.